Self-Developed Product “Treprostinil Injection” Selected for the 《2026 Hefei High-End Industrial Products List》

Recently, the Hefei Municipal Bureau of Industry and Information Technology released the “2026 Hefei High-end Industrial Products List”. Treprostinil Injection (“The Product”, 20ml:20mg & 20ml:50mg), a self-developed product by Zhaoke Pharmaceutical (Hefei) Co., Ltd. (“Zhaoke Hefei”), a wholly-owned subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”, Stock Code: 00950), was successfully listed. […]
The 3rd Sino-Europe Brain and Body Academic Conference 2026 Successfully Concludes: Featured Session on “Frontiers and Clinical Practice in Psycho-Cardiology” and Media Briefing for the Sino-Europe Innovative Medical Education Program

On May 24, the 3rd Sino-Europe Brain and Body Academic Conference entitled “Frontiers and Clinical Practice in Psycho-Cardiology” successfully concluded in Nansha, Guangzhou. Organized by the Chinese Society of Neuroscience, Branch of Basics and Clinical Research in Psychiatry, the conference brought together leading medical experts from China and Europe to spotlight frontier developments and clinical […]
Lee’s Pharm (Zhaoke) Sparkled on The 92nd PharmChina (Shanghai)

On May 13, 2026, The 92nd PharmChina was kicked off at the National Exhibition and Convention Center in Shanghai. As a leading professional trade and exchange exhibition platform for the pharmaceutical and healthcare industry, more than thousands of pharmaceutical companies and 100,000 professionals were gathered at this fair. Lee’s Pharmaceutical Holdings Ltd. (Lee’s Pharm or […]
Matrix Series of China-Europe International Medical Education Programs Won “Italian National Award for Educational Excellence (PEF)”

The award ceremony for the 11th PEF Training Excellence Award (Premio Eccellenza Formazione), promoted by AIF (Associazione Italiana Formatori) under the Italian Association of Educational Trainers, was successfully held in recent days. The Matrix Series of China-Europe International Medical Education Programs, sponsored by Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”, stock code: 00950), […]
Lee’s Pharm Partners with Shaohe Biotech to Translate Probiotics into Public Health Solutions

Lee’s Pharmaceutical Holdings Limited (referred to as “Lee’s Pharm” or “the Group”, stock code: 00950) and Shaohe Biotechnology Co., Ltd., Guangdong (hereinafter referred to as “Shaohe Biotech”) announced a strategic partnership to jointly build a new ecosystem for the probiotic industry. This collaboration aims to translate probiotic research from the laboratory to public health applications, […]
A Recap of 2025 The 2nd Sino-European Brain-Heart Alliance Academic Conference in Shanghai

The 2nd Sino-European Brain-Heart Alliance Academic Conference has been successfully held in Shanghai during June 13–14, 2025. The conference was jointly hosted by the Chinese Neuroscience Society’s Basic and Clinical Psychiatry Subcommittee, the University of Mediterranean Free State in Italy, and the University of Padua in Italy. The event brought together the top medical experts […]
The launch of the new production line at Zhaoke-Hefei manufacturing site

On 8th June 2025, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”, stock code: 00950) announced a significant milestone through its wholly-owned subsidiary Zhaoke Pharmaceutical (Hefei) Co., Ltd. (“Zhaoke-Hefei”)— the launch of the new production line of prefilled filling with isolator. ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: Lee’s Pharmaceutical Holdings – News & Media
⟨ Life and Health China Tour 2025 — Henan Province⟩ Treprostinil Injection (芮旎爾®) Launching Ceremony cum Pulmonary Hypertension Summit Forum

The Pulmonary Hypertension Summit Forum – Henan Province, part of a series of the ⟨Life and Health China Tour 2025⟩, was successfully held on May 24 at the Hilton Hotel in Zhengzhou. The forum gathered cutting-edge research on pulmonary hypertension, exploring topics such as disease mechanisms, targeted drug development, and multidisciplinary treatment model innovations, aiming […]
Dr. LI Xiaoyi, Founder of Lee’s Pharm, attended the “Thematic Seminar on Biotechnology Innovation and Translation Project”

February 26, 2025, the “Thematic Seminar on Biotechnology Innovation and Translation Project”, organized by The Hong Kong Bio-Med Innotech Association (HKBMIA), was successfully held. The seminar aims to share a series of achievements of the project and conduct presentations and discussions on the industry’s hotspots, to explore the innovations of the biopharmaceutical industry and the […]
“STEM Experience Program for Secondary Students —— Kanya Lee Scholarship Recognition Ceremony 2024”

Hong Kong, December 20, 2024 – The “STEM Experience Program for Secondary Students——Kanya Lee Scholarship Recognition Ceremony 2024” was successfully held in Hong Kong Disneyland Hotel. ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: Lee’s Pharmaceutical Holdings – News & Media